Axa S.A. Assembly Biosciences, Inc. Transaction History

Axa S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.87 - $17.29 $1.05 Million - $3.71 Million	-214,738 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$15.08 - $27.04 $31,879 - $57,162	-2,114 Reduced 0.97%	214,738 $3.53 Million
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $156,904 - $258,025	10,769 Added 5.23%	216,852 $5.06 Million
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $157,962 - $326,538	-15,381 Reduced 6.95%	206,083 $3.06 Million
Q4 2019 Feb 18, 2020	SELL	$8.36 - $23.81 $326,424 - $929,685	-39,046 Reduced 14.99%	221,464 $4.53 Million

Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $3,843 - $5,794	-391 Reduced 0.15%	260,510 $2.56 Million
Q2 2019 Aug 13, 2019	BUY	$12.9 - $20.8 $62,242 - $100,360	4,825 Added 1.88%	260,901 $3.52 Million
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $1.45 Million - $2.04 Million	81,814 Added 46.95%	256,076 $5.04 Million
Q3 2018 Nov 08, 2018	BUY	$34.41 - $44.23 $1.2 Million - $1.55 Million	35,000 Added 25.13%	174,262 $6.47 Million
Q2 2018 Aug 13, 2018	BUY	$39.21 - $50.29 $875,402 - $1.12 Million	22,326 Added 19.09%	139,262 $5.46 Million
Q1 2018 May 14, 2018	SELL	$41.7 - $64.16 $52,416 - $80,649	-1,257 Reduced 1.06%	116,936 $5.75 Million
Q4 2017 Feb 13, 2018	SELL	$28.58 - $49.91 $3,686 - $6,438	-129 Reduced 0.11%	118,193 $5.35 Million
Q3 2017 Nov 13, 2017	BUY	$23.08 - $34.92 $2.73 Million - $4.13 Million	118,322	118,322 $4.13 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $640M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.